Congress Asset Management CO Charles River Laboratories International, Inc. Transaction History

Congress Asset Management CO

$13.6 Billion
Q1 2024

A detailed history of Congress Asset Management CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Congress Asset Management CO holds 453,392 shares of CRL stock, worth $91.3 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

453,392

Previous 465,258 2.55%

Holding current value

$91.3 Million

Previous $110 Million 11.69%

% of portfolio

0.9%

Previous 0.89%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$203.52 - $273.43 $2.41 Million - $3.24 Million	-11,866 Reduced 2.55%	453,392 $123 Million
Q4 2023 Mar 04, 2024	SELL	$164.52 - $238.84 $541,928 - $786,738	-3,294 Reduced 0.7%	465,258 $110 Million
Q3 2023 Nov 01, 2023	BUY	$194.44 - $217.61 $281,160 - $314,664	1,446 Added 0.31%	468,552 $91.8 Million
Q2 2023 Jul 27, 2023	BUY	$183.71 - $210.25 $89,283 - $102,181	486 Added 0.1%	467,106 $98.2 Million
Q1 2023 Apr 21, 2023	BUY	$191.89 - $259.92 $2.72 Million - $3.69 Million	14,180 Added 3.13%	466,620 $94.2 Million

Q4 2022 Jan 18, 2023	SELL	$197.11 - $250.07 $5.82 Million - $7.39 Million	-29,537 Reduced 6.13%	452,440 $0
Q3 2022 Nov 08, 2022	BUY	$182.44 - $250.54 $3.69 Million - $5.07 Million	20,222 Added 4.38%	481,977 $94.9 Million
Q2 2022 Aug 02, 2022	BUY	$204.13 - $302.4 $1.82 Million - $2.69 Million	8,910 Added 1.97%	461,755 $98.8 Million
Q1 2022 Apr 20, 2022	BUY	$255.51 - $362.11 $4.95 Million - $7.01 Million	19,355 Added 4.46%	452,845 $129 Million
Q4 2021 Jan 28, 2022	SELL	$351.38 - $448.68 $4.84 Million - $6.19 Million	-13,787 Reduced 3.08%	433,490 $163 Million
Q3 2021 Nov 08, 2021	SELL	$372.64 - $458.3 $8.47 Million - $10.4 Million	-22,741 Reduced 4.84%	447,277 $185 Million
Q2 2021 Aug 05, 2021	SELL	$294.17 - $371.65 $18.9 Million - $23.9 Million	-64,317 Reduced 12.04%	470,018 $174 Million
Q1 2021 May 05, 2021	SELL	$249.67 - $299.48 $15.4 Million - $18.5 Million	-61,615 Reduced 10.34%	534,335 $155 Million
Q4 2020 Jan 26, 2021	SELL	$222.0 - $252.62 $3.94 Million - $4.48 Million	-17,727 Reduced 2.89%	595,950 $149 Million
Q3 2020 Nov 03, 2020	SELL	$175.56 - $226.45 $2.97 Million - $3.83 Million	-16,909 Reduced 2.68%	613,677 $139 Million
Q2 2020 Jul 23, 2020	SELL	$118.84 - $189.72 $1.72 Million - $2.75 Million	-14,507 Reduced 2.25%	630,586 $110 Million
Q1 2020 Apr 21, 2020	SELL	$98.9 - $178.34 $3.7 Million - $6.67 Million	-37,399 Reduced 5.48%	645,093 $81.4 Million
Q4 2019 Feb 10, 2020	SELL	$126.05 - $152.76 $363,906 - $441,018	-2,887 Reduced 0.42%	682,492 $104 Million
Q3 2019 Nov 01, 2019	SELL	$125.07 - $143.67 $2.19 Million - $2.51 Million	-17,486 Reduced 2.49%	685,379 $90.7 Million
Q2 2019 Aug 07, 2019	SELL	$123.4 - $148.55 $6.04 Million - $7.28 Million	-48,983 Reduced 6.52%	702,865 $99.7 Million
Q1 2019 May 08, 2019	SELL	$104.82 - $146.73 $1.75 Million - $2.45 Million	-16,686 Reduced 2.17%	751,848 $109 Million
Q4 2018 Jan 25, 2019	SELL	$105.09 - $137.23 $4.59 Million - $5.99 Million	-43,672 Reduced 5.38%	768,534 $87 Million
Q3 2018 Oct 26, 2018	SELL	$112.11 - $134.54 $1.71 Million - $2.05 Million	-15,235 Reduced 1.84%	812,206 $109 Million
Q2 2018 Jul 25, 2018	SELL	$102.37 - $117.25 $383,682 - $439,453	-3,748 Reduced 0.45%	827,441 $92.9 Million
Q1 2018 May 11, 2018	BUY	$98.19 - $115.2 $5.88 Million - $6.9 Million	59,910 Added 7.77%	831,189 $88.7 Million
Q4 2017 Jan 30, 2018	BUY	$100.43 - $118.09 $1.53 Million - $1.8 Million	15,201 Added 2.01%	771,279 $84.4 Million
Q3 2017 Oct 17, 2017	BUY	$96.72 - $109.26 $73.1 Million - $82.6 Million	756,078	756,078 $81.7 Million

Others Institutions Holding CRL

# of Institutions

728

Shares Held

51.3M

Call Options Held

183K

Put Options Held

346K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.2B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.

Account

Congress Asset Management CO Charles River Laboratories International, Inc. Transaction History